[Important aim of statin therapy: ischemic cardiovascular event (stroke)]
Related Experiment Videos
1Allami Egészségügyi Központ, II. Belgyógyászati Osztály, Budapest.
Insights
Statins effectively prevent coronary heart disease and initial strokes by lowering LDL-cholesterol. High-dose atorvastatin also shows promise in preventing recurrent strokes, highlighting their crucial role in cardiovascular health.
Area of Science:
- Cardiology
- Neurology
- Pharmacology
Background:
- Statins are established for coronary heart disease (CHD) prevention.
- Evidence suggests statins inhibit first-time cerebrovascular infarct (stroke).
- Efficacy correlates with LDL-cholesterol reduction, with potential pleiotropic effects.
Purpose of the Study:
- To evaluate the role of statins in primary and secondary stroke prevention.
- To assess the impact of LDL-cholesterol reduction on statin efficacy for stroke prevention.
- To examine the effect of high-dose atorvastatin on recurrent stroke development.
Main Methods:
- Review of numerous studies and meta-analyses on statin treatment.
- Analysis of data from the SPARCL study (Stroke Prevention by Aggressive Reduction in Cholesterol Levels).
- Assessment of both cholesterol-dependent and independent (pleiotropic) effects of statins.
Main Results:
- Statins demonstrate efficacy in preventing initial strokes, with greater LDL-cholesterol reduction leading to better outcomes.
- Statin's effect on stroke prevention is less robust than on coronary vessels.
- High-dose (80 mg) atorvastatin was shown to prevent recurrent stroke development in the SPARCL study.
Conclusions:
- Statins are authorized for coronary heart disease prevention and show effectiveness in primary stroke prevention.
- Pleiotropic actions of statins contribute to their cardiovascular benefits.
- High-dose atorvastatin represents a significant advancement in secondary stroke prevention.
Abstract:
Statin's treatment clearly is authorized in prevention of coronary heart disease (CHD). According to the results of many studies and meta-analyses statins can inhibit the first cerebrovascular infarct (stroke). The greater the decrease of LDL-cholesterol level the more prominent the efficacy. The effect is not so robust compared to coronary vessels moreover clear pleiotropic (cholesterol independent) action takes also part. It has been nowadays revealed that high dose (80 mg) atorvastatin can confine first time the development of recurrence stroke (SPARCL study), which is an important fact in the field of secondary prevention.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management
Coronary Artery Disease V: Interprofessional Care
Ischemic Stroke l: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...